Cysteamine derivatives and their use in the treatment of NASH

Details for Australian Patent Application No. 2011263423 (hide)

Owner Kandula, M.

Inventors Kandula, Mahesh

Agent Spruson & Ferguson

Pub. Number AU-A-2011263423

PCT Pub. Number WO2011/154833

Priority 61/352,438 08.06.10 US

Filing date 3 June 2011

Wipo publication date 15 December 2011

International Classifications

C07D 339/04 Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms

A61K 31/385 - having two or more sulfur atoms in the same ring

A61P 1/16 Drugs for disorders of the alimentary tract or the digestive system

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/154833 Priority application(s): WO2011/154833

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011263436-4, 6 -dibenzoylamino2 -methylpyrimidine derivatives and their use for the treatment of cancer

2011263261-Refastenable fastening system for wearing article